INT315846

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.00
First Reported 2009
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.45
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

D1Mit315 (Mus musculus)
D1Mit315 - T315I (1)
Pain Link Frequency Relevance Heat
Central nervous system 7 5.00 Very Low Very Low Very Low
Potency 4 5.00 Very Low Very Low Very Low
corticosteroid 2 5.00 Very Low Very Low Very Low
headache 2 5.00 Very Low Very Low Very Low
cytokine 1 5.00 Very Low Very Low Very Low
rheumatoid arthritis 1 5.00 Very Low Very Low Very Low
imagery 1 5.00 Very Low Very Low Very Low
cva 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Myeloid Leukemia 85 80.48 Quite High
Disease 7 77.60 Quite High
Cancer 6 74.16 Quite High
Leukemia 15 50.00 Quite Low
Pleural Effusion 18 5.00 Very Low Very Low Very Low
Toxicity 6 5.00 Very Low Very Low Very Low
Recurrence 6 5.00 Very Low Very Low Very Low
Neutropenia 6 5.00 Very Low Very Low Very Low
Pressure And Volume Under Development 5 5.00 Very Low Very Low Very Low
Thrombocytopenia 4 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
A possible strategy to suppress the outgrowth of resistant clones is the combination of dasatinib or the other Bcr-Abl TKIs with an inhibitor of T315I.
Negative_regulation (inhibitor) of T315I (T315I)
1) Confidence 0.00 Published 2009 Journal OncoTargets and therapy Section Body Doc Link PMC2886328 Disease Relevance 0.45 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox